Hormonal therapies and venous thrombosis: Considerations for prevention and management.

Corinne LaVasseurSuvi NeukamThomas Kartika Bethany T Samuelson BannowJoseph ShatzelThomas G DeLoughery

Published in: Research and practice in thrombosis and haemostasis (2022)

When contemplating hormonal contraception or hormone replacement therapy, clinicians must consider a variety of factors including hormone type, dose, route, personal and family history of thrombosis, and other prothrombotic risk factors to make informed, personalized decisions regarding the risk of venous thrombosis.

Keyphrases

replacement therapy
risk factors
smoking cessation
polycystic ovary syndrome
pulmonary embolism
palliative care
type diabetes
insulin resistance